Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects

Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects

Abstract Background Ezetimibe is a new class of antihyperlipidemic agent indicated for the prevention of atherosclerosis disease and for the treatment of hypercholesterolemia. Information on the pharmacokinetic profiles of ezetimibe tablet in healthy Chinese volunteers are lacking, and regulatory re...

Full description

Bibliographic Details
Main Authors: Feifei Sun, Yanping Liu, Ting Li, Pingping Lin, Xin Jiang, Xin Li, Chenjing Wang, Xiaomeng Gao, Yaping Ma, Yao Fu, Yu Cao
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Pharmacology and Toxicology
Subjects:
Ezetimibe tablet
Ezetimibe glucuronide
Bioequivalence
Pharmacokinetics
Healthy volunteers
Online Access:https://doi.org/10.1186/s40360-023-00649-y

Internet

https://doi.org/10.1186/s40360-023-00649-y

Similar Items